Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 338 participants.

Also called NCT01361594

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 338 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01361594
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01361594. Randomized; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2013-12 (actual). Results posted on 2014-12-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery
Condition
Diabetes
Intervention (Other)
Regular insulin (intensive treatment)
Intervention (Other)
Regular Insulin (conventional treatment)
Lead sponsor
Emory University (class: other)
Collaborator
American Diabetes Association (class: other)

Record details

Record id
cardio:ct-nct01361594
Content hash
e19c62d8b5a60683d9e7467f49cb4ed57f2a0dcc3135ceb2386655c6834f1860